Cargando…

Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer

Resistance to chemotherapy is widely recognized as one of the major factors limiting therapeutic efficacy and influences clinical outcomes in patients with cancer. Many studies on various tumor types have focused on combining standard-of-care chemotherapy with immunotherapy. However, for cervical ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Heeren, A. Marijne, van Luijk, Iske F., Lakeman, Joost, Pocorni, Noëlle, Kole, Jeroen, de Menezes, Renée X., Kenter, Gemma G., Bosse, Tjalling, de Kroon, Cornelis D., Jordanova, Ekaterina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851216/
https://www.ncbi.nlm.nih.gov/pubmed/31616965
http://dx.doi.org/10.1007/s00262-019-02412-x